{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:46:14Z","timestamp":1757591174195},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,11,29]],"date-time":"2009-11-29T00:00:00Z","timestamp":1259452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s11926-009-0059-4","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T06:19:43Z","timestamp":1259389183000},"page":"402-409","source":"Crossref","is-referenced-by-count":24,"title":["Systemic vasculitis in childhood"],"prefix":"10.1007","volume":"11","author":[{"given":"Abraham","family":"Gedalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Cuchacovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,29]]},"reference":[{"key":"59_CR1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00467-006-0181-8","volume":"21","author":"M.J. Dillon","year":"2006","unstructured":"Dillon MJ, Ozen S: A new international classification of childhood vasculitis. Pediatr Nephrol 2006, 21:1219\u20131222.","journal-title":"Pediatr Nephrol"},{"key":"59_CR2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.2005.046300","volume":"65","author":"S. Ozen","year":"2006","unstructured":"Ozen S, Ruperto N, Dillon MJ, et al.: EULAR\/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006, 65:936\u2013941.","journal-title":"Ann Rheum Dis"},{"key":"59_CR3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11926-004-0068-2","volume":"6","author":"A. Gedalia","year":"2004","unstructured":"Gedalia A: Henoch-Sch\u00f6nlein purpura. Curr Rheumatol Rep 2004, 6:195\u2013202.","journal-title":"Curr Rheumatol Rep"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/adc.2004.066035","volume":"93","author":"E.J. Tizard","year":"2008","unstructured":"Tizard EJ, Hamilton-Ayres MJ: Henoch-Sch\u00f6nlein purpura. Arch Dis Child Ed Pract 2008, 93:1\u20138.","journal-title":"Arch Dis Child Ed Pract"},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/art.1780330809","volume":"33","author":"J.A. Mills","year":"1990","unstructured":"Mills JA, Michel BA, Bloch DA, et al.: The American College of Rheumatology 1990 criteria for the classification of Henoch-Sch\u00f6nlein purpura. Arthritis Rheum 1990, 33:1114\u20131121.","journal-title":"Arthritis Rheum"},{"key":"59_CR6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archfami.9.6.553","volume":"9","author":"A.K. Shetty","year":"2000","unstructured":"Shetty AK, Dessele BC, Ey JL, et al.: Infantile Henoch-Sch\u00f6nlein purpura. Arch Fam Med 2000, 9:553\u2013556.","journal-title":"Arch Fam Med"},{"key":"59_CR7","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00467-007-0623-y","volume":"22","author":"K.K. Lau","year":"2007","unstructured":"Lau KK, Wayett RJ, Moldoveanu Z, et al.: Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura. Pediatr Nephrol 2007, 22:2067\u20132072.","journal-title":"Pediatr Nephrol"},{"key":"59_CR8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/adc.78.3.240","volume":"78","author":"M. Fujieda","year":"1998","unstructured":"Fujieda M, Oishi N, Naruse K, et al.: Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Sch\u00f6nlein purpura. Arch Dis Child 1998, 78:240\u2013244.","journal-title":"Arch Dis Child"},{"key":"59_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2431-8-33","volume":"8","author":"S. Fessatou","year":"2008","unstructured":"Fessatou S, Nicolaidou P, Gourgiotis D, et al.: Endothelin 1 levels in relation to clinical presentation and outcome of Henoch-Sch\u00f6nlein purpura. BMC Pediatr 2008, 8:33.","journal-title":"BMC Pediatr"},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00467-007-0450-1","volume":"22","author":"P.A. Brogan","year":"2007","unstructured":"Brogan PA: What\u2019s new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 2007, 22:1083\u20131094.","journal-title":"Pediatr Nephrol"},{"key":"59_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0009922808323113","volume":"48","author":"M. Karreman","year":"2009","unstructured":"Karreman M, Jordan AJ, Bell N et al.: Acute hemorrhagic edema of infancy: report of 4 cases and review of the current literature. Clin Pediatr 2009, 48:323\u2013326.","journal-title":"Clin Pediatr"},{"key":"59_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-2-7","volume":"2","author":"A. Huber","year":"2004","unstructured":"Huber Am, King J, McLaine P, et al.: A randomized, placebo-controlled trial of prednisone in early Henoch-Sch\u00f6nlein purpura (ISRCTN85109383). BMC Med 2004, 2:7.","journal-title":"BMC Med"},{"key":"59_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","volume":"149","author":"J. Ronkainen","year":"2006","unstructured":"Ronkainen J, Koskimeies O, la-Houhala M, et al.: Early prednisone therapy in Henoch-Sch\u00f6nlein purpura: a randomized double-blind, placebo-controlled trial. J Pediatr 2006, 149:241\u2013247.","journal-title":"J Pediatr"},{"key":"59_CR14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00296-002-0208-9","volume":"22","author":"S. Singh","year":"2002","unstructured":"Singh S, Devidayal, Kumar L, et al.: Severe Henoch-Sch\u00f6nlein nephritis: resolution with azathioprine and steroids. Rheumatol Int 2002, 22:133\u2013137.","journal-title":"Rheumatol Int"},{"key":"59_CR15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10067-005-0066-4","volume":"25","author":"J.I. Shin","year":"2006","unstructured":"Shin JI, Park JM, Lee JS, et al.: Successful use of cyclosporine A in severe Sch\u00f6nlein-Henoch nephritis resistant to both methylprednisolone pulse and azathioprine. Clin Rheumatol 2006, 25:759\u2013760.","journal-title":"Clin Rheumatol"},{"key":"59_CR16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1542\/peds.2007-0667","volume":"120","author":"P.F. Weiss","year":"2007","unstructured":"Weiss PF, Feinstein JA, Luan X, et al.: Effects of corticosteroid on Henoch-Sch\u00f6nlein purpura nephritis: a systematic review. Pediatr 2007, 120:1079\u20131087.","journal-title":"Pediatr"},{"key":"59_CR17","doi-asserted-by":"crossref","unstructured":"Kawasaki Y, Suzuki J, Nozawa R, et al.: Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Sch\u00f6nlein nephritis. Pediatrics 2003, 785\u2013789.","DOI":"10.1542\/peds.111.4.785"},{"key":"59_CR18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/adc.2008.141820","volume":"94","author":"W. Chartapisak","year":"2009","unstructured":"Chartapisak W, Opastirakul S, Willis N, et al.: Prevention and treatment of renal disease in Henoch-Schonlein purpura: a systematic review. Arch Dis Child 2009, 94:132\u2013137.","journal-title":"Arch Dis Child"},{"key":"59_CR19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1651-2227.2001.tb01370.x","volume":"90","author":"T. Lamireau","year":"2001","unstructured":"Lamireau T, Rebouissoux L, Hehunstre JP: Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch-Sch\u00f6nlein purpura. Acta Pediatr 2001, 90:1081\u20131082.","journal-title":"Acta Pediatr"},{"key":"59_CR20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00467-007-0498-y","volume":"22","author":"M. Shenoy","year":"2007","unstructured":"Shenoy M, Ognjanovic MV, Coulthard MG: Treating severe Henoch-Sch\u00f6nlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 2007, 22:1167\u20131171.","journal-title":"Pediatr Nephrol"},{"key":"59_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5414\/CNP60153","volume":"60","author":"Y. Kawasaki","year":"2003","unstructured":"Kawasaki Y, Suzuki J, Sakai N, et al.: Clinical and pathological features of children with Henoch-Sch\u00f6nlein nephritis: risk factors associated with poor prognosis. Clin Nephrol 2003, 60:153\u2013160.","journal-title":"Clin Nephrol"},{"key":"59_CR22","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/adc.2005.074641","volume":"90","author":"H. Narchi","year":"2005","unstructured":"Narchi H: Risk of long term renal impairment and duration of follow up recommended for Henoch-Sch\u00f6nlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005, 90:916\u2013920.","journal-title":"Arch Dis Child"},{"key":"59_CR23","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","volume":"114","author":"J.W. Newberger","year":"2004","unstructured":"Newberger JW, Takahashi M, Gerber MA, et al.: Endorsed clinical report, AAP, AHA: guidance for the clinicians in rendering pediatric care. Pediatrics 2004, 114:1708\u20131733.","journal-title":"Pediatrics"},{"key":"59_CR24","first-page":"1141","volume":"74","author":"A.F. Freeman","year":"2006","unstructured":"Freeman AF, Shulman ST: Kawasaki disease: summary of the American Heart Association Guidelines. Am Fam Physicians 2006, 74:1141\u20131148.","journal-title":"Am Fam Physicians"},{"key":"59_CR25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1442-200X.2006.02221.x","volume":"48","author":"H. Yanagawa","year":"2006","unstructured":"Yanagawa H, Nakamura Y, Yashiro M, et al.: Incidence of Kawasaki disease in Japan: the nationwide survey of 1999\u20132002. Pediatr Int 2006, 48:356\u2013361.","journal-title":"Pediatr Int"},{"key":"59_CR26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jpeds.2009.03.013","volume":"155","author":"T. Suenaga","year":"2009","unstructured":"Suenaga T, Suzuki H, Shibuta S, et al.: Detection of multiple superantigen genes in stool of patients with Kawasaki syndrome. Pediatr 2009, 155:266\u2013270.","journal-title":"Pediatr"},{"key":"59_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOP.0b013e328012720f","volume":"19","author":"A.H. Rowley","year":"2007","unstructured":"Rowley AH, Shulman ST: New developments in the search for etiologic agent of Kawasaki disease. Curr Opin Pediatr 2007, 19:71\u201374.","journal-title":"Curr Opin Pediatr"},{"key":"59_CR28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-200x.2005.02049.x","volume":"47","author":"K. Takahashi","year":"2005","unstructured":"Takahashi K, Oharaseki T, Naoe S, et al.: Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int 2005, 47:305\u2013310.","journal-title":"Pediatr Int"},{"key":"59_CR29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/adc.2005.087437","volume":"91","author":"H. Senzaki","year":"2006","unstructured":"Senzaki H: The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child 2006, 91:847\u2013851.","journal-title":"Arch Dis Child"},{"key":"59_CR30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/000992280504400812","volume":"44","author":"W.M. Abuhammour","year":"2005","unstructured":"Abuhammour WM, Hasan RA, Eljamal A, Asmar B: Kawasaki disease hospitalizations in a predominantly African-American population. Clin Pediatr 2005, 44:721\u2013725.","journal-title":"Clin Pediatr"},{"key":"59_CR31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00246-005-0916-5","volume":"26","author":"A.R. Porcalla","year":"2005","unstructured":"Porcalla AR, Sable CA, Patel KM, et al.: The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms? Pediatr Cardiol 2005, 26:775\u2013781.","journal-title":"Pediatr Cardiol"},{"key":"59_CR32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0027-9684(15)31171-8","volume":"100","author":"J. Marquez","year":"2007","unstructured":"Marquez J, Gedalia O, Candia L, et al.: Kawasaki disease: clinical spectrum of 88 patients in a high prevalence African American population. J Natl Med Assoc 2007, 100:28\u201332.","journal-title":"J Natl Med Assoc"},{"key":"59_CR33","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/CIRCULATIONAHA.106.179568","volume":"114","author":"R.E. Kavey","year":"2006","unstructured":"Kavey RE, Allada V, Daniels SR, et al.: Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the AHA expert panel on population and prevention science. Circulation 2006, 114:2710\u20132738.","journal-title":"Circulation"},{"key":"59_CR34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jhg.2008.9","volume":"54","author":"A. Hata","year":"2009","unstructured":"Hata A, Onouchi Y: Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine. J Hum Genet 2009, 54:67\u201373.","journal-title":"J Hum Genet"},{"key":"59_CR35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00246-009-9441-2","volume":"30","author":"N. Dahdah","year":"2009","unstructured":"Dahdah N, Siles A, Fournier A, et al.: Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki Disease. Pediatr Cardiol 2009, 30:810\u2013817.","journal-title":"Pediatr Cardiol"},{"key":"59_CR36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jpeds.2006.05.025","volume":"149","author":"Y. Inoue","year":"2006","unstructured":"Inoue Y, Okada Y, Shinohara M, et al.: Multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 2006, 149:336\u2013341.","journal-title":"J Pediatr"},{"key":"59_CR37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa061235","volume":"356","author":"J.W. Newburger","year":"2007","unstructured":"Newburger JW, Sleeper LA, McCrindle BW, et al.: Randomized trial of pulsed corticosteroids therapy for primary for treatment of Kawasaki disease. N Engl J Med 2007, 356:663\u2013675.","journal-title":"N Engl J Med"},{"key":"59_CR38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","volume":"153","author":"J.C. Burns","year":"2008","unstructured":"Burns JC, Best BM, Mejias A, et al.: Infliximab treatment for intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr 2008, 153:833\u2013838.","journal-title":"J Pediatr"},{"key":"59_CR39","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1203\/PDR.0b013e31819ed68d","volume":"65","author":"K. Hirono","year":"2009","unstructured":"Hirono K, Kemmotsu Y, Wittkowski H, et al.: Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in with refractory Kawasaki Disease. Pediatr Res 2009, 65:696\u2013701.","journal-title":"Pediatr Res"},{"key":"59_CR40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1546-0096-7-3","volume":"7","author":"R.J. Brogan","year":"2009","unstructured":"Brogan RJ, Eleftheriou D, Gnanapragasam J, et al.: Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report. BMC Pediatr Rheumatol 2009, 7:3.","journal-title":"BMC Pediatr Rheumatol"},{"key":"59_CR41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2007.04.062","volume":"151","author":"F. Yal\u00e7inkaya","year":"2007","unstructured":"Yal\u00e7inkaya F, Oz\u00e7akar ZB, Kasap\u00e7opur O, et al.: Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 2007, 151:675\u2013678.","journal-title":"J Pediatr"},{"key":"59_CR42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.rdc.2007.07.007","volume":"33","author":"F. Dedeoglu","year":"2007","unstructured":"Dedeoglu F, Sundel RP: Vasculitis in children. Rheum Dis Clin N Am 2007, 33:555\u2013583.","journal-title":"Rheum Dis Clin N Am"},{"key":"59_CR43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10067-005-0071-7","volume":"25","author":"S.W. Kort de","year":"2006","unstructured":"de Kort SW, van Rossum MA, ten Juvy CR: Infliximab in a child with therapy-resistant systemic vasculitis. Clin Rheumatol 2006, 25:769\u2013771.","journal-title":"Clin Rheumatol"},{"key":"59_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2177\/jsci.31.119","volume":"31","author":"K. Sonomoto","year":"2008","unstructured":"Sonomoto K, Miyamura T, Watanabe H, et al.: A case of polyarteritis nodosa successfully treated by rituximab [in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi 2008, 31:119\u2013123.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"59_CR45","first-page":"196","volume":"26","author":"S. Ozen","year":"2007","unstructured":"Ozen S, Bakkaloglu A, Dusunsel R, et al.: Turkish Pediatric Vasculitis Study Group: childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 2007, 26:196\u2013200.","journal-title":"Clin Rheumatol"},{"key":"59_CR46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1546-0096-6-17","volume":"6","author":"S. Abrawi Al","year":"2008","unstructured":"Al Abrawi S, Fouillet-Desjonqueres M, David L, et al.: Takayasu arteritis in children. Pediatr Rheumatol Online 2008, 6:17.","journal-title":"Pediatr Rheumatol Online"},{"key":"59_CR47","first-page":"913","volume":"35","author":"N. Cakar","year":"2008","unstructured":"Cakar N, Yalcinkaya F, Duzova A, et al.: Takayasu\u2019s arteritis in children. J Rheumatol 2008, 35:913\u2013919.","journal-title":"J Rheumatol"},{"key":"59_CR48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/ard.61.6.526","volume":"61","author":"V.P. Aluquin","year":"2002","unstructured":"Aluquin VP, Albano SA, Chan F, et al.: Magnetic resonance imaging in the diagnosis and follow up of Takayasu arteritis in children. Ann Rheum Dis 2002, 61:526\u2013529.","journal-title":"Ann Rheum Dis"},{"key":"59_CR49","first-page":"335","volume":"16","author":"A.K. Shetty","year":"1998","unstructured":"Shetty AK, Stopa AR, Gedalia A: Low dose methotrexate as a steroid-sparing agent in a child with Takayasu arteritis. Clin Exp Rheumatol 1998, 16:335\u2013336.","journal-title":"Clin Exp Rheumatol"},{"key":"59_CR50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jpeds.2008.04.049","volume":"153","author":"G. Filocamo","year":"2008","unstructured":"Filocamo G, Buoncompagni A, Viola S, et al.: Treatment of Takayasu\u2019s arteritis with tumor necrosis factor antagonists. J Pediatr 2008, 153:432\u2013434.","journal-title":"J Pediatr"},{"key":"59_CR51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/BOR.0b013e3282f3177a","volume":"20","author":"J. Elbers","year":"2008","unstructured":"Elbers J, Benseler SM: Central nervous system vasculitis in children. Curr Opin Rheumatol 2008, 20:47\u201354.","journal-title":"Curr Opin Rheumatol"},{"key":"59_CR52","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ncprheum0860","volume":"4","author":"S. Cantez","year":"2008","unstructured":"Cantez S, Benseler S: Childhood CNS vasculitis: a treatable cause of neurological deficit in children. Nat Clin Pract Rheumatol 2008, 4:460\u2013461.","journal-title":"Nat Clin Pract Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0059-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-009-0059-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0059-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:49:52Z","timestamp":1559436592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-009-0059-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,29]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s11926-009-0059-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,29]]}}}